SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
29 avr. 2024 09h15 HE | Sanara MedTech Inc.
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
10 avr. 2024 09h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09 avr. 2024 09h05 HE | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
04 avr. 2024 09h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26 mars 2024 09h00 HE | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
25 mars 2024 16h05 HE | Sanara MedTech Inc.
FORT WORTH, TX, March 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 févr. 2024 17h10 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
22 févr. 2024 09h15 HE | Sanara MedTech Inc.
FORT WORTH, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
13 févr. 2024 16h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
SeaStar_SM_LogoCard.png
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
26 janv. 2024 08h05 HE | SeaStar Medical Holding Corporation
DENVER, Jan. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (the “Company”), a medical technology company developing proprietary solutions to reduce the consequences...